TAP
51
6
LMT
27
-2
OKE
65
4
ADP
65
4
HAL
50
3
UNH
50
-5
AAL
48
6
TEL
60
-6
HPQ
52
3
BBY
43
3
XRX
30
2
UHS
56
4
PYPL
41
2
AIZ
47
-2
AVGO
25
-2
NWL
54
-2
WBA
48
-2
ADI
47
-2
AMG
22
-16
HP
36
3
TAP
51
6
LMT
27
-2
OKE
65
4
ADP
65
4
HAL
50
3
UNH
50
-5
AAL
48
6
TEL
60
-6
HPQ
52
3
BBY
43
3
XRX
30
2
UHS
56
4
PYPL
41
2
AIZ
47
-2
AVGO
25
-2
NWL
54
-2
WBA
48
-2
ADI
47
-2
AMG
22
-16
HP
36
3
Financhill
Back

Bio-Rad Laboratories 10K Form

Buy
59

BIO
Bio-Rad Laboratories

Last Price:
361.67
Seasonality Move:
8.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIO News And Ratings

See the #1 stock for the next 7 days that we like better than BIO

BIO Financial Statistics

Sales & Book Value

Annual Sales: $2.67B
Cash Flow: $99.97M
Price / Cash Flow: 46.87
Annual Sales: $267.46
Price / Book: 1.38

Profitability

EPS (TTM): -27.33000
Net Income (TTM): $-778.69M
Gross Margin: $1.43B
Return on Equity: -9.62%
Return on Assets: -6.82%

Bio-Rad Laboratories Earnings Forecast

Key Bio-Rad Laboratories Financial Ratios

  • The Gross Profit Margin over the past 40 years for BIO is 53.42%.
  • The Selling, General & Administrative Expenses for BIO have been equal to 31.51% of Gross Profit Margin.
  • The Research & Development expenses have been 9.26% of Revenue.
  • The Interest Expense is -7.76% of Operating Income.
  • The Net Earning history of BIO is -23.86% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 27 years.

Bio-Rad Laboratories Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: BIO
CUSIP: 090572
Website: bio-rad.com

Debt

Debt-to-Equity Ratio: 0.16
Current Ratio: 6.14
Quick Ratio: 4.19

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 32.16

BIO Technical Analysis vs Fundamental Analysis

Buy
59
Bio-Rad Laboratories (BIO) is a Buy

Is Bio-Rad Laboratories a Buy or a Sell?